Evaluation of recombinant factor VIIa treatment for massive hemorrhage in patients with multiple traumas

about

Evaluation of recombinant factor VIIa treatment for massive hemorrhage in patients with multiple traumas

Item

http://www.wikidata.org/entity/Q35788608

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Evaluation of recombinant fact ...... patients with multiple traumas

@ast

Evaluation of recombinant fact ...... patients with multiple traumas

@en

type

Item

label

Evaluation of recombinant fact ...... patients with multiple traumas

@ast

Evaluation of recombinant fact ...... patients with multiple traumas

@en

prefLabel

Evaluation of recombinant fact ...... patients with multiple traumas

@ast

Evaluation of recombinant fact ...... patients with multiple traumas

@en

P1476

Evaluation of recombinant fact ...... patients with multiple traumas

@en

P2093

Chulhun L Chang

http://www.w3.org/2001/XMLSchema#string

Eun Yup Lee

http://www.w3.org/2001/XMLSchema#string

Han Chul Son

http://www.w3.org/2001/XMLSchema#string

Hyung Hoi Kim

http://www.w3.org/2001/XMLSchema#string

Seok Ran Yeom

http://www.w3.org/2001/XMLSchema#string

Suck Ju Cho

http://www.w3.org/2001/XMLSchema#string

Young Rae Koh

http://www.w3.org/2001/XMLSchema#string

P2860

Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia

Structure of human factor VIIa and its implications for the triggering of blood coagulation

Transfusion medicine service policies for recombinant factor VIIa administration.

Recombinant activated coagulation factor VII and bleeding trauma patients.

Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications

Efficacy and safety of recombinant factor VIIa in the prophylaxis of bleeding in various surgical procedures in hemophilic patients with factor VIII and factor IX inhibitors.

Recombinant factor VIIa for control of hemorrhage: early experience in critically ill trauma patients.

Pharmacokinetics of recombinant activated factor VII in trauma patients with severe bleeding

Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: subgroup analysis from two randomized trials

Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding.

P304

145-152

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3343/ALM.2012.32.2.145

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-02-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221887596

http://www.w3.org/2001/XMLSchema#string

P698

22389882

http://www.w3.org/2001/XMLSchema#string

P932

3289780

http://www.w3.org/2001/XMLSchema#string